Drug
MHB088C for Injection
MHB088C for Injection is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph phase_3
1
25%
Ph phase_1
3
75%
Phase Distribution
3
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 13 (75.0%)
Phase 31 (25.0%)
Trials by Status
not_yet_recruiting125%
recruiting375%
Recent Activity
3 active trials
Showing 4 of 4
recruitingphase_1
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
NCT07126665
recruitingphase_1
Study of MHB088C for Patients With Advanced Solid Malignant Tumors
NCT07102004
recruitingphase_3
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06954246
not_yet_recruitingphase_1
Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors
NCT05652855
Clinical Trials (4)
Showing 4 of 4 trials
NCT07126665Phase 1
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
NCT07102004Phase 1
Study of MHB088C for Patients With Advanced Solid Malignant Tumors
NCT06954246Phase 3
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT05652855Phase 1
Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4